---
title: "ANRO: Precision psychiatry pipeline advances with biomarker-driven therapies and strong clinical data"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295708046.md"
description: "A precision medicine approach leverages biomarkers to advance a late-stage pipeline targeting major mental health disorders. Lead candidates ALTO-207, ALTO-300, and ALTO-100 show strong efficacy, improved tolerability, and commercial potential, supported by robust financials and an experienced leadership team.Original document: Alto Neuroscience, Inc. [ANRO] Slides Release — Aug. 12 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-12T20:44:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295708046.md)
  - [en](https://longbridge.com/en/news/295708046.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295708046.md)
generator: "portal-rs"
---

# ANRO: Precision psychiatry pipeline advances with biomarker-driven therapies and strong clinical data

A precision medicine approach leverages biomarkers to advance a late-stage pipeline targeting major mental health disorders. Lead candidates ALTO-207, ALTO-300, and ALTO-100 show strong efficacy, improved tolerability, and commercial potential, supported by robust financials and an experienced leadership team.

Original document: Alto Neuroscience, Inc. \[ANRO\] Slides Release — Aug. 12 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ANRO.US](https://longbridge.com/en/quote/ANRO.US.md)

## Related News & Research

- [Alto Neuroscience posts corporate presentation outlining precision psychiatry drug pipeline, led by ALTO-207 in treatment-resistant depression](https://longbridge.com/en/news/295705980.md)
- [Silicon Valley wealth managers say elite tech workers are making these 5 money moves as AI mania continues](https://longbridge.com/en/news/297398623.md)
- [Palo Alto’s Rally Has One Big Problem Ahead of Earnings](https://longbridge.com/en/news/297518798.md)
- [Palo Alto Networks (PANW) On AI Security Optimism And Why The Stock Still Looks Pricey](https://longbridge.com/en/news/297408307.md)
- [TScan Therapeutics cuts workforce 75% in reorganization to focus on in vivo solid tumor cell therapy](https://longbridge.com/en/news/297773935.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**